Abstract
Drug use in combination with psychiatric illness may lead to unsafe sexual risk behavior and increased risk for secondary HIV transmission among adolescents with HIV infection. We compared the prevalence of substance use for perinatally HIV-infected youth to uninfected adolescents living in families affected by HIV infection, and evaluated the association of psychiatric symptoms with risk of substance use. Among 299 adolescents (196 HIV+, 103 HIV−) aged 12–18 years enrolled in IMPAACT P1055, a multisite US cohort study, 14% reported substance use at enrollment (HIV+: 13%, HIV−: 16%). In adjusted logistic regression models, adolescents had significantly higher odds of substance use if they met symptom criteria for ADHD [adjusted odds ratio (aOR) = 2.7, Wald χ2 = 5.18, P = 0.02], major depression or dysthymia (aOR = 4.0, Wald χ2 = 7.36, P = 0.01), oppositional defiant disorder (aOR = 4.8, Wald χ2 = 12.7, P = 0.001), or conduct disorder (aOR = 15.4, Wald χ2 = 28.12, P = 0.001). Among HIV-infected youth, those with lower CD4 lymphocyte percentage (CD4% < 25%) had significantly increased risk of substance use (aOR = 2.7, Wald χ2 = 4.79, P = 0.03). However, there was no overall association of substance use with HIV infection status, and the association between psychiatric symptoms and substance use did not differ by HIV status. Programs to prevent substance use should target both HIV-infected and uninfected adolescents living in families affected by HIV infection, particularly those with psychiatric symptoms.
Similar content being viewed by others
References
Kure K, Llena JF, Lyman WD, Soeiro R, Weidenheim KM, Hirano A, Dickson DW. Human Immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. Hum Pathol. 1991;22(7):700–10.
Blumberg BM, Gelbard HA, Epstein LG. HIV-1 infection of the developing nervous system: central role of astrocytes in pathogenesis. Virus Res. 1994;32(2):253–67.
Brown LK, Lourie KJ, Pao M. Children and adolescents living with HIV and AIDS: a review. J Child Psychol Psychiatry. 2000;41(1):81–96.
Nozyce ML, Lee SS, Wiznia A, Nachman S, Mofenson LM, et al. A behavioral and cognitive profile of clinically stable HIV-infected children. Pediatrics. 2006;117(3):763–70.
Jeremy RJ, Kim S, Nozyce M, Nachman S, McIntosh K, et al. Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children. Pediatrics. 2005;115(2):380–7.
Mellins CA, Brackis-Cott E, Dolezal C, Abrams EJ. Psychiatric disorders in youth with perinatally acquired human immunodeficiency virus infection. Pediatr Infect Dis J. 2006;25(5):432–7.
Scharko AM. DSM psychiatric disorders in the context of pediatric HIV/AIDS. AIDS Care. 2006;18(5):441–5.
Gaughan DM, Hughes MD, Oleske JM, Malee K, Gore CA, Nachman S, for the PACTG 219C Team. Psychiatric hospitalizations among children and youths with human immunodeficiency virus infection. Pediatrics 2004;113(6):e544–51.
Mellins CA, Smith R, O’Driscoll P, Magder LS, Brouwers P, et al. High rates of behavioral problems in perinatally HIV-infected children are not linked to HIV disease. Pediatrics. 2003;111(2):384–93.
Mellins CA, Brackis-Cott E, Leu C-S, et al. Rates and types of psychiatric disorders in perinatally human immunodeficiency virus-infected youth and seroreverters. J Child Psychol Psychiatry. 2009;50(9):1131–8.
Chernoff M, Nachman S, Williams PL, Brouwers P, Heston J et al. for the IMPAACT P1055 Team. Mental health treatment patterns in perinatally HIV-infected youth and controls. Pediatrics 2009;124(2):627–636.
Gadow K, Chernoff M, Williams PL, Brouwers P, Morse E, Heston J, Hodge J, DiPoalo V, Deygoo NS, Nachman S, the PACTG P1055 Study Team. Co-occurring psychiatric symptoms in children perinatally-infected with HIV and peer comparison sample. J Dev Behav Pediatr. 2010;31:116–128.
Bose S, Moss H, Brouwers P, Pizzo P, Lorion R. Psychological adjustment of human immunodeficiency virus-infected school-age children. J Dev Behav Pediatr. 1994;15(3 Suppl):S26–33.
Havens JF, Whitaker AH, Feldman J, Ehrhardt AA. Psychiatric morbidity in school-age children with congenital human immunodeficiency virus infection: a pilot study. J Dev Behav Pediatr. 1994;15(3 Suppl):S18–25.
Lee SJ, Detels R, Rotheram-Borus MJ, Duan N. The effect of social support on mental and behavioral outcomes among adolescents with parents with HIV/AIDS. Am J Public Health. 2007;97(10):1820–6.
Bauman LJ, Silver EJ, Draimin BH, Hudis J. Children of mothers with HIV/AIDS: unmet needs for mental health services. Pediatrics. 2007;120(5):e1141–7.
Whitmore SK, Zhang Z, Taylor AW. Estimated number of births to HIV-positive women, United States, 2006. In: 16th conference on retroviruses and opportunistic infections, Montreal 2009, abstract #924.
Martel MM, Pierce L, Nigg JT, Jester JM, Adams K, et al. Temperament pathways to childhood disruptive behavior and adolescent substance abuse: testing a cascade model. J Abnorm Child Psychol. 2009;37:363–73.
Burke JD, Loeber R, Lahey BB, Rathouz PJ. Developmental transitions among affective and behavioral disorders in adolescent boys. J Child Psychol Psychiatry. 2005;46(11):1200–10.
Molina BSG, Pelham WE. Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. J Abnorm Psychol. 2003;112(3):497–507.
Tarter RE, Kirisci L, Feske U, Vanyukov M. Modeling the pathways linking childhood hyperactivity and substance use disorder in young adulthood. Psychol Addict Behav. 2007;21(2):266–71.
Zucker RA. Alcohol use and the alcohol use disorders: a developmental-biopsychosocial systems formulation covering the life course. In: Cicchetti D, Cohen KJ, editors. Developmental psychopathology: risk, disorder, and adaptation. vol 3. Hoboken, New Jersey: Wiley;2006. p. 620–656.
Massé LC, Tremblay RE. Behavior of boys in kindergarten and the onset of substance use during adolescence. Arch Gen Psychiatry. 1997;54:62–8.
Serchuck L, Williams PL, Nachman S, Gadow KD, Chernoff M, Schwartz L, for the IMPAACT 1055 Team. Prevalence of pain and association with psychiatric symptom severity in perinatally HIV-infected and HIV-Uninfected children and adolescents. AIDS Care. 2010;16:1–9. [Epub ahead of print. doi:10.1080/09540120903280919].
Gadow K, Sprafkin J. Child and adolescent symptom inventory-4R. Stony Brook: Checkmate Plus; 2005.
Gadow KD, Sprafkin J. Youth’s inventory-4 manual. Stony Brook: Checkmate Plus; 1999.
Gadow KD, Sprafkin J, Carlson GA, Schneider J, Nolan EE, Mattison RE, et al. A DSM-IV-referenced, adolescent self-report rating scale. J Am Acad Child Adolesc Psychiatry. 2002;41(6):671–9.
Button TM, Rhee SH, Hewitt JK, Young SE, Corley RP, Stallings MC. The role of conduct disorder in explaining the comorbidity between alcohol and illicit drug dependence in adolescence. Drug Alcohol Depend. 2007;87:46–53.
Rotheram-Borus MJ, Lee M, Zhou S, O’Hara P, Birnbaum JM, et al. the Teens Linked to Care Consortium. Variation in health and risk behavior among youth living with HIV. AIDS Educ Prev. 2001;13(1):42–54.
American Academy of Pediatrics Committee on Pediatric AIDS. Reducing the risk of HIV infection associated with illicit drug use. Pediatrics. 2006;117:566–71.
Bailey SL, Gao W, Clark DB. Diary study of substance use and unsafe sex among adolescents with substance use disorders. J Adolesc Health. 2006;38(3):297.e13–20.
Beyers JM, Toumbourou JW, Catalano RF, Arthur MW, Hawkins JD. A cross-national comparison of risk and protective factors and adolescent substance use: the United States and Australia. J Adolesc Health. 2004;35:3–16.
Gonzalez R, Vassileva J, Bechara J, Grbesic S, Sworowski L, et al. The influence of executive functions, sensation seeking, and HIV serostatus on the risky sexual practices of substance-dependent individuals. J Int Neuropsychol Soc. 2005;11:121–31.
Malow RM, Dévieux JG, Rosenberg R, Samuels DM, Jean-Gilles MM. Alcohol use severity and HIV sexual risk among juvenile offenders. Subst Use Misuse. 2006;41:1769–88.
Prado G, Schwartz SJ, Pattatucci-Aragón A, Clatts M, Pautin H, et al. The prevention of HIV transmission in Hispanic adolescents. Drug Alcohol Depend. 2006;84S:S43–53.
Thompson JC, Kao TC, Thomas RJ. The relationship between alcohol use and risk-taking sexual behaviors in a large behavioral study. Prev Med. 2005;41:247–52.
Hanson RF, Self-Brown S, Fricker-Elhai A, Kilpatrick DG, Saunders BE, Resnick H. Relations among parental substance use, violence exposure and mental health: the national survey of adolescents. Addict Behav. 2006;31:1988–2001.
Kamon JL, Stranger C, Budeney AJ, Dumenci L. Relations between parent and adolescent problems among adolescents presenting for family-based marijuana abuse treatment. Drug Alcohol Depend. 2006;85:244–54.
Acknowledgments
We would like to thank Kimberly Hudgens for her operational support of this study and Janice Hodge for data management. We express our gratitude for Dr. Pim Brouwers’ guidance on this project and his extensive scientific expertise regarding psychiatric conditions in relation to perinatal HIV. We also acknowledge with great appreciation the help given by Nagamah Sandra Deygoo in representing the site research staff on the protocol team. Finally, we thank the institutions and site staff who enrolled participants to IMPAACT P1055, as listed in Appendix. The trial sponsors are National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Mental Health (NIMH), and Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
Funding
Overall support for the IMPAACT Group was provided by the National Institute of Allergy and Infectious Diseases [U01 AI068632] and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of Mental Health (NIMH). These institutions were involved in the design, data collection and conduct of P1055, but were not involved in the present analysis, the interpretation of the data, the writing of the manuscript, or the decision to submit for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work was supported by the Statistical and Data Analysis Center at Harvard School of Public Health, under the National Institute of Allergy and Infectious Diseases cooperative agreement #1 U01 AI-41110 with the Pediatric AIDS Clinical Trials Group (PACTG) and #1 U01 AI068616 with the IMPAACT Group. Support of the sites was provided by the NIAID and the NICHD International and Domestic Pediatric and Maternal HIV Clinical Trials Network funded by NICHD (contract number N01-DK-9-001/HHSN267200800001C).
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was conducted for the IMPAACT 1055 Team. The institutions and the site staff who enrolled participants to IMPAACT P1055, are listed in Appendix.
Appendix
Appendix
Institutions and site staff who enrolled participants to the study IMPAACT P1055, conducted by the International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) group:
Children’s Hospital Boston, Div. of Infectious Diseases: S Burchett; UCLA-Los Angeles/Brazil AIDS Consortium: K Nielsen, N Falgout, J Geffen, JG Deville; Long Beach Memorial Medical Center, Miller Children’s Hospital: A Deveikis; Harbor—UCLA Medical Center—Dept. of Peds, Div. of Infectious Diseases: M Keller; Univ. of Maryland Med. Ctr., Div. of Ped. Immunology & Rheumatology: V Tepper; Chicago Children’s: R Yogev; UCSF Pediatric AIDS CRS: D Wara; UCSD Maternal, Child, and Adolescent HIV: SA Spector, L Stangl, M Caffery, R Viani; DUMC Ped; K Whitfield, S Patil, J Wilson, MJ Hassett; New York University: S Deygoo, W Borkowsky, S Chandwani, M Rigaud; Jacobi Medical Center Bronx: A Wiznia; Univ. of Washington Children’s Hosp. Seattle; L Frenkel; USF—Tampa: P Emmanuel, J Zilberman, C Rodriguez, C Graisbery; Mount Sinai School of Medicine, NY: R Posada, MS Dolan; San Juan City Hospital: M Acevedo-Flores, L Angeli, M Gonzalez, D Guzman; Yale Univ. School of Medicine—Dept. of Peds., Div. of Infectious Disease: WA Andiman, L Hurst, A Murphy; SUNY Upstate Med. Univ., Dept. of Peds: L Weiner; SUNY Stony Brook: D Ferraro, M Kelly, L Rubino; Howard Univ. Washington DC: S Rana; University of Southern California: S Kapetanovic; Univ. of Florida Jacksonville: MH Rathore, A Mirza, K Thoma, C Griggs; Univ. of Colorado Denver: R McEvoy, E Barr, S Paul, P Michalek; South Florida CDC Ft Lauderdale: A Puga; St. Jude/UTHSC: P Garvie; The Children’s Hosp. of Philadelphia: R Rutstein; St. Christopher’s Hosp. for Children: R LaGuerre; Bronx-Lebanon Hospital: M Purswani; Metropolitan Hospital Center: M Bamji; WNE Maternal Pediatric Adolescent AIDS: K Luzuriaga.
Rights and permissions
About this article
Cite this article
Williams, P.L., Leister, E., Chernoff, M. et al. Substance Use and its Association with Psychiatric Symptoms in Perinatally HIV-infected and HIV-Affected Adolescents. AIDS Behav 14, 1072–1082 (2010). https://doi.org/10.1007/s10461-010-9782-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10461-010-9782-0